Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)

Nycomed

Status: Completed

Conditions: Common Cold

Treatments: Drug: xylometazoline hydrochloride and ipratropium bromide (ZyComb)

Study type: Observational

Funder types: Industry

Identifiers

NCT00480194

XY-005-IM

Details and patient eligibility

About

The objectives of the study are to obtain knowledge about the safety in use, the patients' general impression of the treatment and the pattern of use of ZyComb® in an over-the-counter (OTC) setting.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• For inclusion the patient must buy ZyComb® nasal spray with the intention to start using it either the same or the next day.